Rockwell Medical Inc reports results for the quarter ended June 30 - Earnings Summary

Rockwell Medical

13/08/2026 12:01

Rockwell Medical Inc RMTI.OQ reported a quarterly adjusted loss of 34 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -50 cents.  The mean expectation of two analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -30 cents to -17 cents per share.
Revenue rose 10.6% to $17.78 million from a year ago; analysts expected $17.84 million. 
Rockwell Medical Inc's reported EPS for the quarter was a loss of 34 cents​.
The company reported a quarterly loss of $1.17 million.
Rockwell Medical Inc shares had risen by 36.4% this quarter and lost 9.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 6% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for Rockwell Medical Inc is $30.00, about 75% above its last closing price of $7.51
This summary was machine generated from LSEG data August 13 at 11:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.23
-0.34
Missed
Mar. 31 2026 
-0.25
-0.40
Missed
Dec. 31 2025 
0.20
-0.10
Missed
Sep. 30 2025 
-0.45
-0.50
Missed